Olema Pharmaceuticals, Inc. OLMA
7.35 USD +0.28 (+3.96%)
At closeNov 3, 2026, 4:27 PM EST
7.49 +0.14 +1.90%
After hours · Nov 3, 4:27 PM ET
7.00 Day range 7.41
6.24 52-week range 36.26
- YTD
- -70.60%
- 1 year
- -12.71%
Held by funds
108 US ETFs and mutual funds hold OLMA · largest positions
Ownership
Held by insiders 1.77%
Held by institutions 118.48%
Float held by institutions 120.62%
Institutions 256
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 11.89% | 10,386,845 | 125.16M | Mar 30, 2026 |
| Paradigm Biocapital Advisors LP | 9.18% | 8,020,576 | 96.65M | Mar 30, 2026 |
| Bain Capital Life Sciences Investors, LLC | 8.56% | 7,473,238 | 90.05M | Mar 30, 2026 |
| Janus Henderson Group PLC | 8.14% | 7,108,488 | 85.66M | Mar 30, 2026 |
| Blackrock Inc. | 7.69% | 6,714,691 | 80.91M | Jun 29, 2026 |
| BVF Inc. | 6.06% | 5,295,893 | 63.82M | Mar 30, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.10% | 2,706,903 | 32.62M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.78% | 2,427,390 | 29.25M | Mar 30, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.36% | 2,058,609 | 24.81M | Jun 29, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.83% | 1,600,000 | 19.28M | Jun 29, 2026 |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.63% | 1,422,771 | 17.14M | Jun 29, 2026 |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 0.92% | 800,000 | 9.64M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AUSTIN SASHA LU | Officer | Stock Award(Grant) | Feb 1, 2026 | 16,188 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 7, 2025 | 0 |
| BOHEN SEAN | Chief Executive Officer | Stock Gift | Dec 25, 2025 | 237,650 |
| GRAHAM G. WALMSLEY | Director | Purchase | Dec 16, 2024 | 0 |
| HARMON CYRUS | Director | Sale | Jul 23, 2026 | 819,798 |
| KOVACS SHANE WILLIAM CHARLES | Chief Operating Officer | Sale | Jan 14, 2026 | 139,727 |